Prostaglandins in pathogenesis and treatment of multiple sclerosis

Plasma levels of 15d-PGJ2are not altered in multiple sclerosis

(2009) M. Comabella et al.   EUROPEAN JOURNAL OF NEUROLOGY

Gender and sex hormones in multiple sclerosis pathology and therapy

(2009) Arnaud Nicot   Frontiers in Bioscience-Landmark

TheCTLA-4gene polymorphisms are associated with CTLA-4 protein expression levels in multiple sclerosis patients and with susceptibility to disease

(2009) Lidia Karabon et al.   IMMUNOLOGY

IL-2, IFN-γ, and IL-12 Gene Polymorphisms and Susceptibility to Multiple Sclerosis

(2009) Mohammad Ali Shokrgozar et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Elevated cerebrospinal fluid levels of prostaglandin E2 and 15-(S)-hydroxyeicosatetraenoic acid in multiple sclerosis

(2009) N. Mattsson et al.   JOURNAL OF INTERNAL MEDICINE

Genetic association between polymorphisms in the BTG1 gene and multiple sclerosis

(2009) M. Camiña-Tato et al.   JOURNAL OF NEUROIMMUNOLOGY

Association of susceptibility to multiple sclerosis in Southern Han Chinese with HLA-DRB1, -DPB1 alleles and DRB1-DPB1 haplotypes: distinct from other populations

(2009) Xiao-Mu Wu et al.   Multiple Sclerosis Journal

The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain

(2009) E. Ramil et al.   Multiple Sclerosis Journal

Protective role of the HLA–A*02 allele in Portuguese patients with multiple sclerosis

(2009) AM Silva et al.   Multiple Sclerosis Journal

Prostaglandin E2–EP4 signaling promotes immune inflammation through TH1 cell differentiation and TH17 cell expansion

(2009) Chengcan Yao et al.   NATURE MEDICINE

Association between Protective and Deleterious HLA Alleles with Multiple Sclerosis in Central East Sardinia

(2009) Roberta Pastorino et al.   PLoS One

Targeted lipidomics reveals mPGES-1-PGE2 as a therapeutic target for multiple sclerosis

(2009) Y. Kihara et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

CD24 gene polymorphism is associated with the disease progression and susceptibility to multiple sclerosis in the Iranian population

(2009) Mohammad Ronaghi et al.   PSYCHIATRY RESEARCH

Analysis of HLA DR2&DQ6 (DRB1*1501, DQA1*0102, DQB1*0602) Haplotypes in Iranian Patients with Multiple Sclerosis

(2008) Mojdeh Ghabaee et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

Cyclooxygenase-2 in Synaptic Signaling

(2008) Hongwei Yang et al.   CURRENT PHARMACEUTICAL DESIGN

EVI5 is a risk gene for multiple sclerosis

(2008) I A Hoppenbrouwers et al.   GENES AND IMMUNITY

Antioxidant therapy in multiple sclerosis

(2008) Abbas Mirshafiey et al.   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

15-Deoxy-Δ12,14-Prostaglandin J2 and Curcumin Modulate the Expression of Toll-like Receptors 4 and 9 in Autoimmune T Lymphocyte

(2008) Wanida Chearwae et al.   JOURNAL OF CLINICAL IMMUNOLOGY

The SH2D2A gene and susceptibility to multiple sclerosis

(2008) Åslaug R. Lorentzen et al.   JOURNAL OF NEUROIMMUNOLOGY

Blockade of cytosolic phospholipase A2α prevents experimental autoimmune encephalomyelitis and diminishes development of Th1 and Th17 responses

(2008) S MARUSIC et al.   JOURNAL OF NEUROIMMUNOLOGY

Lipoic acid stimulates cAMP production via the EP2 and EP4 prostanoid receptors and inhibits IFN gamma synthesis and cellular cytotoxicity in NK cells

(2008) Sonemany Salinthone et al.   JOURNAL OF NEUROIMMUNOLOGY

The genetics of multiple sclerosis: SNPs to pathways to pathogenesis

(2008) Jorge R. Oksenberg et al.   NATURE REVIEWS GENETICS

Association of the PPARγ gene polymorphism Pro12Ala with delayed onset of multiple sclerosis

(2008) Luisa Klotz et al.   NEUROSCIENCE LETTERS

Reciprocal Interactions Between Human Mesenchymal Stem Cells and γδ T Cells Or Invariant Natural Killer T Cells

(2008) Ignazia Prigione et al.   STEM CELLS

Regulation of Glial Cell Functions by PPAR- Natural and Synthetic Agonists

(2008) Antonietta Bernardo et al.   PPAR Research